.beta.-l-2'-deoxynucleosides for the treatment of resistant...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7076 (2006.01) A61K 31/7052 (2006.01) A61K 31/7064 (2006.01) A61K 31/7068 (2006.01) A61K 31/7072 (2006.01) A61K 38/21 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2498731

It has been discovered that .szlig.-L-2'-deoxynucleosides are active against drug~resistant hepatitis B virus with mutations. A method for treating lamivudine resistant HBV (M552V) in a host is provided that includes administering a .szlig.-L-2'~deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug. In addition, a method for preventing lamivudine resistant HBV (M552V) mutation from occurring in a naïve host is provided that includes administering a .szlig.-L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug. A method for preventing and/or suppressing the emergence of the HBV double mutant (L528M/M552V) in a host is also provided that includes administering a (3-L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug.

On a découvert que les .szlig.-L-2'-désoxynucléosides étaient actifs contre les virus mutants de l'hépatite B résistant aux médicaments. Dans ce cadre, l'invention porte sur un procédé de traitement du VHB (M552V) résistant à la lamivudine dans un hôte consistant à lui administrer un .szlig.-L-2'-désoxynucléoside ou ses sels, esters ou promédicaments pharmacocompatibles. L'invention porte également sur un procédé empêchant les mutations du VHB (M552V) résistant à la lamivudine de se produire dans un hôte naïf, consistant à lui administrer un .szlig.-L-2'-désoxynucléoside ou ses sels, esters ou promédicaments pharmacocompatibles, et sur un procédé prévenant et/ou supprimant l'apparition dans un hôte d'un double mutant du VHB (L528M/M552V), consistant à lui administrer un .szlig.-L-2'-désoxynucléoside ou ses sels, esters ou promédicaments pharmacocompatibles

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

.beta.-l-2'-deoxynucleosides for the treatment of resistant... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with .beta.-l-2'-deoxynucleosides for the treatment of resistant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-l-2'-deoxynucleosides for the treatment of resistant... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1411982

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.